Back to Journals » OncoTargets and Therapy » Volume 9 » Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Please verify you are not a robot.